Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service

"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS

Ergebnis verändern

einschränken: Volltextzugriff; Academic (peer-reviewed) journals
erweitern: Auch Volltexte der Artikel durchsuchen; Verwandte Themen suchen

Publikationstyp

Thema

erschienen in

Verlag

Geographic terms

Sprache

Datenbank

Erscheinungsjahr

Von:

Bis:

Treffer 1 - 25 von 2975, Suchdauer: 1.04s

12 3 4 5 6 7 8 9 10 11 weiter »

1
Efficacy and safety of avapritinib in advanced systemic mastocytosis: 4-year follow-up of the PATHFINDER study

von Jason Gotlib ; Andreas Reiter ; Deepti H. Radia ; et al.

Blood Advances, Vol 10, Iss 10, Pp 3676-3689 (2026)

Schlagworte: Specialties of internal medicine; RC581-951
- View full text via DOI
Merkliste

2
Anaphylaxis events in the PIONEER study of avapritinib in indolent systemic mastocytosis

von Thanai Pongdee, MD ; Mariana Castells, MD, PhD ; Cem Akin, MD ; et al.

World Allergy Organization Journal, Vol 19, Iss 4, Pp 101352- (2026)

Schlagworte: Anaphylaxis; Indolent systemic mastocytosis; Avapritinib; Immunologic diseases. Allergy; RC581-607
- View full text via DOI
Merkliste

3
Incidence of blast phase in myelofibrosis according to anemia severity

von Barbara Mora ; Margherita Maffioli ; Elisa Rumi ; et al.

eJHaem, Vol 4, Iss 3, Pp 679-689 (2023)

Schlagworte: acute myeloid leukemia; essential thrombocythemia; myelofibrosis; polycythemia vera; ruxolitinib; Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

4
Risk stratification of patients with TP53-mutated myeloproliferative neoplasms

von Rolles, Benjamin ; Filho, Cilomar Martins de Oliveira ; Fergusson, Nathan ; et al.

Leukemia. 40(4):773-782
- Zum Volltext (via ReDI)
Merkliste

5
P1023: AVAPRITINIB IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS (ADVSM): EFFICACY AND SAFETY ANALYSES FROM THE PHASE 2 PATHFINDER STUDY WITH 2-YEAR FOLLOW-UP

von Jason Gotlib ; Andreas Reiter ; Deepti Radia ; et al.

HemaSphere, Vol 7, p e3184876 (2023)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

6
P1022: PHASE 1/2 STUDY OF THE ACTIVIN RECEPTOR-LIKE KINASE 2 (ALK2) INHIBITOR ZILURGISERTIB (INCB000928, LIMBER-104) AS MONOTHERAPY OR WITH RUXOLITINIB IN PATIENTS WITH ANEMIA DUE TO MYELOFIBROSIS

von Prithviraj Bose ; Sanjay Mohan ; Stephen Oh ; et al.

HemaSphere, Vol 7, p e41693dd (2023)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

7
S167: EFFICACY AND SAFETY OF LUSPATERCEPT FOR THE TREATMENT OF ANEMIA IN PATIENTS WITH MYELOFIBROSIS: RESULTS FROM THE ACE-536-MF-001 STUDY

von Aaron T. Gerds ; Claire Harrison ; Jean-Jacques Kiladjian ; et al.

HemaSphere, Vol 7, p e0882611 (2023)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

8
P1017: REDUCTIONS IN INDOLENT SYSTEMIC MASTOCYTOSIS BIOMARKER BURDEN WITH AVAPRITINIB IN THE REGISTRATIONAL, DOUBLE-BLIND PLACEBO-CONTROLLED PIONEER TRIAL

von Jason Gotlib ; Mariana Castells ; Hanneke Oude Elberink ; et al.

HemaSphere, Vol 7, p e7796003 (2023)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

9
Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial

von Srdan Verstovsek ; Lynda Foltz ; Vikas Gupta ; et al.

Haematologica, Vol 108, Iss 10 (2023)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

10
Genomic profiling for decision-making in post–polycythemia vera and post–essential thrombocythemia myelofibrosis

von Mora, Barbara ; Palandri, Francesca ; Guglielmelli, Paola ; et al.

In Blood 2 July 2026 148(1):43-57
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

11
Avapritinib improves cutaneous involvement in patients with indolent systemic mastocytosis: Results from the randomized, phase 2, interventional PIONEER study

von Siebenhaar, Frank ; Broesby-Olsen, Sigurd ; Castells, Mariana ; et al.

In Journal of the American Academy of Dermatology June 2026 94(6):1705-1713
- View full text via DOI
Merkliste

12
European LeukemiaNet Response Predicts Disease Progression but Not Thrombosis in Polycythemia Vera

von Douglas Tremblay ; Andrew Srisuwananukorn ; Lukas Ronner ; et al.

HemaSphere, Vol 6, Iss 6, p e721 (2022)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

13
Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal

von Peter Valent ; Cem Akin ; Karin Hartmann ; et al.

HemaSphere, Vol 5, Iss 11, p e646 (2021)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

14
Platelet transcriptome identifies progressive markers and potential therapeutic targets in chronic myeloproliferative neoplasms

von Zhu Shen ; Wenfei Du ; Cecelia Perkins ; et al.

Cell Reports Medicine, Vol 2, Iss 10, Pp 100425- (2021)

Schlagworte: platelet transcriptome; biomarker; progression signatures; prediction algorithms; platelet RNA-seq; myeloproliferative neoplasms; Medicine (General); R5-920
- View full text via DOI
Merkliste

15
A phase 2 study of brentuximab vedotin in patients with CD30-positive advanced systemic mastocytosis

von Jason Gotlib ; John H. Baird ; Tracy I. George ; et al.

Blood Advances, Vol 3, Iss 15, Pp 2264-2271 (2019)

Schlagworte: Specialties of internal medicine; RC581-951
- View full text via DOI
Merkliste

16
Oncogenic SF3B1 mutations alter the splicing of mRNA noncoding regions to induce a novel therapeutic vulnerability

von Sekrecki, Michal ; Sekrecka, Agata ; Lattupally, Rohan R. ; et al.

In Blood 23 April 2026 147(17):1941-1957
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

17
Coronal Heating as Determined by the Solar Flare Frequency Distribution Obtained by Aggregating Case Studies

von Mason, James Paul ; Werth, Alexandra ; West, Colin G. ; et al.

Schlagworte: Astrophysics - Solar and Stellar Astrophysics
- View full text via Arxiv
Merkliste

18
Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patients

von Barbara Mora ; Elisa Rumi ; Paola Guglielmelli ; et al.

Cancer Medicine, Vol 8, Iss 9, Pp 4089-4092 (2019)

Schlagworte: JAK inhibitors; second malignancy; secondary myelofibrosis; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

19
Core‐binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I‐CBFit)

von Celalettin Ustun ; Elizabeth Morgan ; Erica E. M. Moodie ; et al.

Cancer Medicine, Vol 7, Iss 9, Pp 4447-4455 (2018)

Schlagworte: acute myeloid leukemia; core‐binding factor; disease‐free survival; KIT mutation; predictive value; relapse; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

20
Avapritinib achieves long-term disease control with favorable safety in patients with indolent systemic mastocytosis over 3 years

von Akin, Cem ; Sabato, Vito ; Gotlib, Jason ; et al.

In The Journal of Allergy and Clinical Immunology April 2026
- View full text via DOI
Merkliste

21
KIT-Targeting Drugs in the Management of Nonadvanced and Advanced Systemic Mastocytosis

von Reiter, Andreas ; Rossignol, Julien ; Deininger, Michael W. ; et al.

In The Journal of Allergy and Clinical Immunology: In Practice January 2026 14(1):44-52
- View full text via DOI
Merkliste

22
Sustained Complete Molecular Remission With Imatinib Monotherapy in a Child Presenting With Blast Phase FIP1L1-PDGFRA-Associated Myeloid Neoplasm With Eosinophilia

von Juhi Jain ; Elizabeth P. Weinzierl ; Debra Saxe ; et al.

HemaSphere, Vol 4, Iss 6, p e486 (2020)

Schlagworte: Diseases of the blood and blood-forming organs; RC633-647.5
- View full text via DOI
Merkliste

23
Intricate and Cell Type-Specific Populations of Endogenous Circular DNA (eccDNA) in Caenorhabditis elegans and Homo sapiens

von Massa J. Shoura ; Idan Gabdank ; Loren Hansen ; et al.

G3: Genes, Genomes, Genetics, Vol 7, Iss 10, Pp 3295-3303 (2017)

Schlagworte: C. elegans; circular DNAs; eccDNA; 3D genome architecture; circulome; mucin; Genetics; QH426-470
- View full text via DOI
Merkliste

24
Trispecific killer engager CD16xIL15xCD33 potently induces NK cell activation and cytotoxicity against neoplastic mast cells

von Hyun Don Yun ; Martin Felices ; Daniel A. Vallera ; et al.

Blood Advances, Vol 2, Iss 13, Pp 1580-1584 (2018)

Schlagworte: Specialties of internal medicine; RC581-951
- View full text via DOI
Merkliste

25
Prognostic impact of expression of CD2, CD25, and/or CD30 in/on mast cells in systemic mastocytosis: a registry study of the European Competence Network on Mastocytosis

von Rüfer, Axel ; Nilius, Henning ; Hermine, Olivier ; et al.

Leukemia. 39(3):675-683
- Zum Volltext (via ReDI)
Merkliste

12 3 4 5 6 7 8 9 10 11 weiter »

Sie haben nicht gefunden, wonach Sie gesucht haben? Diese Services können Ihnen weiterhelfen.
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag